Login Start free

Focus

Drug Discovery Investors: Angels and VC Firms

The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

4,683: Drug Discovery investors
239: Angel investors
4,444: People at VC/PE firms
1,313: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

4,683 Drug Discovery investors

Showing 281-300

Filters

Viewing

Drug Discovery4,683

Investor Type

Choosing one replaces Drug Discovery.

Investment Stage

Choosing one replaces Drug Discovery.

Seed84,745
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,477

Investment Profile

Choosing one replaces Drug Discovery.

SaaS63,483
FinTech54,183
Healthcare53,462
Consumer46,735
AI46,189
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

Country

Choosing one replaces Drug Discovery.

City

Choosing one replaces Drug Discovery.

Focus1

Investor	Location	Type	Markets	Contact	Actions
David Vacherand Denand Senior Vice President, CP Investment at Lombard Odier Group	Geneva, Switzerland	Family Office	ClimateFinTech		View profile
Giuliano Marostica Managing Partner at TCGX	New York, United States	Private equity	Healthcare		View profile
Asmi Chakraborty Director at Massachusetts Life Sciences Center	Cambridge, United States	Government-backed	EducationHealthcare		View profile
Rick Gibb Co-Founder at Bioverge Ventures	San Francisco, United States	Syndicate / Angel groupVenture capital	AIHardware		View profile
Katie Stolp Director at Morgan Stanley	London, United Kingdom	Corporate VCPrivate equity	FinTechHardware		View profile
David Cecere Board Member and North Texas / Oklahoma Chapter President at Crohn's & Colitis Foundation	Dallas, United States	Family OfficePrivate equity	ClimateHealthcare		View profile
Andrey Gvozd Affiliated at Farmak	Ukraine	Corporate VC	AIHealthcare		View profile
Tiffany Luck Partner at New Enterprise Associates (NEA)	New York, United States	Venture capital	AICommerce		View profile
Joni Mancini Managing Partner at Medical Excellence Capital	Manhasset, United States	Venture capital	Healthcare		View profile
Preston Noon Co-Founder at Agent Capital	Boston, United States	Venture capital	AIHealthcare		View profile
Ti Zhao Partner at Pack Ventures	San Francisco, United States	AcceleratorSyndicate / Angel group	AICommerce		View profile
Marina Pellón-Consunji Partner at Ampersand Capital Partners	Amsterdam, Netherlands	Private equity	CommerceHardware		View profile
David Peng Consultant, Alexandria Venture Investments at Alexandria Real Estate Equities	San Carlos, United States	Corporate VC	HealthcareReal Estate		View profile
Tyler Carney Investor at RA Capital Management	New York, United States	Private equityVenture capital	FinTechHealthcare		View profile
Catherine Pagliarulo Senior Vice President at Alexandria Real Estate Equities	Boston, United States	Corporate VC	HealthcareReal Estate		View profile
Bill Fisher Senior Consultant at Celgene	Chattanooga, United States	Corporate VC	Healthcare		View profile
Sammit Purandare Chartered Accountant at CSL	Frankfurt, Germany	Corporate VC	Healthcare		View profile
Joshua J. Carson Principal at Wisconsin Alumni Research Foundation (WARF)	Madison, United States	Venture capital	AIHardware		View profile
John Corcoran Investor at Trinity Life Sciences	Waltham, United States	AcceleratorCorporate VC	AIHealthcare		View profile
Yoichiro Taku Partner at Wilson Sonsini Goodrich & Rosati	Palo Alto, United States	Corporate VC	AIClimate		View profile

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal